相关实验视频

Updated: May 26, 2025

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

在早期诊断肌缩性侧面硬化症的进展

Pilar H García-Casanova^1,2, Juan F Vázquez-Costa^1,2,3,4

¹ALS Unit, Department of Neurology, Hospital Universitario y Politécnico La Fe, Valencia, Spain.

Expert review of neurotherapeutics

|February 25, 2025

概括

减少肌缩侧面硬化症 (ALS) 的诊断延迟至关重要. 早期诊断,专家转诊和医生教育是改善患者结果和临床试验参与的关键策略.

科学领域:

神经学神经学
神经退行性疾病神经退行性疾病

背景情况:

肌缩侧面硬化症 (ALS) 是一种快速进展的神经退行性疾病.
持续存在10-16个月的显著诊断延迟,影响及时干预和护理.
减少这种延迟对于有效的多学科护理和临床试验招生至关重要.

研究的目的:

探索导致ALS诊断延迟的因素.
突出早期ALS诊断的重要性.
确定改善诊断时间表的策略.

主要方法:

从1990年到2024年,对PubMed索引的研究进行系统审查.
分析影响诊断延迟的因素.
诊断标准和潜在生物标志物的评估.

主要成果:

临床专业知识是ALS诊断延迟的主要可修改因素.
生物标志物显示出早期诊断的潜力,但在临床实施方面面临挑战.
缺乏疾病特异性生物标志物和延迟结果是重大障碍.

结论:

早期转诊到ALS专家和医生教育对于减少诊断延迟至关重要.
对于未来的改进,需要开发特定疾病的生物标志物.
优化诊断途径对于更好的ALS患者管理至关重要.

关键词:

肌缩性侧面硬化症 (AMLS) 是一种疾病.黄金海岸标准黄金海岸标准诊断延迟是因为诊断延迟.流体生物标志物流体生物标志物图像成像生物标志物神经纤维光链的光链.

更多相关视频

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...